Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.52 |
| ▸ | CCKAR | P32238 | 16/20 | 0.48 |
| ▸ | CCKBR | P32239 | 15/20 | 0.48 |
| ▸ | YWHAZ | P63104 | 2/20 | 0.46 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16408401 | 0.75 | GLP1R (0.40) | ALBCCKARCCKBRYWHAZ | |
| SCHEMBL23599906 | 0.74 | FTO (0.51) | ALB | |
| SCHEMBL917141 | 0.74 | ALB (0.58) | ALB | |
| SCHEMBL13794742 | 0.73 | CCKAR (0.51) | CCKARCCKBR | |
| SCHEMBL24691602 | 0.73 | CCKAR (0.55) | CCKARCCKBRIL23R | |
| SCHEMBL25138002 | 0.73 | FTO (0.52) | ALB | |
| SCHEMBL14144739 | 0.72 | ALB (0.51) | ALB | |
| SCHEMBL12964684 | 0.72 | ALB (0.44) | ALB | |
| SCHEMBL14769921 | 0.71 | ALB (0.65) | ALB | |
| SCHEMBL24723090 | 0.71 | FTO (0.51) | ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238458-A1 | COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF | PURDUE RESEARCH FOUNDATION | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238458-A1 | COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF | FAP, FIBP, FGFR1 | ALB 174/4885CCKAR 3871/4885CCKBR 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.